| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Radiology, Vol 190, 111-116, Copyright © 1994 by Radiological Society of North America
ARTICLES |
JS Newman, IR Francis, MS Kaminski and RL Wahl
Department of Radiology, University of Michigan Hospitals, Ann Arbor 48109-0028.
PURPOSE: To prospectively compare the accuracy of positron emission tomography (PET) with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (FDG) in imaging thoracicoabdominal lymphoma to that of computed tomography (CT). MATERIALS AND METHODS: Sixteen patients with lymphoma (11 with non-Hodgkin lymphoma [NHL] and five with Hodgkin disease) underwent FDG- PET and CT. Blinded, independent interpretations of PET and CT studies were followed by a direct comparison of the images. Measurement of tumor uptake of FDG was performed on positive PET studies. RESULTS: Fifty-four foci of abnormal uptake were detected with PET in 13 patients. Forty-nine corresponding sites of lymphadenopathy and/or masses were detected with CT. All sites of adenopathy seen at CT were detected at PET. Three patients with Hodgkin disease had negative findings at abdominal PET, CT, and subsequent staging laparotomy. FDG uptake was comparable for both the low- and intermediate-grade lymphomas. CONCLUSION: These preliminary data indicate excellent accuracy for FDG-PET imaging of thoracicoabdominal lymphoma. All grades of NHL were successfully imaged with FDG-PET. PET appears to be a useful method for imaging lymphoma.
This article has been cited by other articles:
|
|
 |
|
  M. de Wit, W. Brenner, M. Hartmann, J. Kotzerke, D. Hellwig, J. Lehmann, C. Franzius, S. Kliesch, M. Schlemmer, K. Tatsch, et al. [18F]-FDG-PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial Ann. Onc., May 16, 2008; (2008) mdn170v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Seam, M. E. Juweid, and B. D. Cheson The role of FDG-PET scans in patients with lymphoma Blood, November 15, 2007; 110(10): 3507 - 3516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Zinzani, M. Tani, R. Trisolini, S. Fanti, V. Stefoni, M. Alifano, P. Castellucci, G. Musuraca, G. Dalpiaz, L. Alinari, et al. Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma Haematologica, June 1, 2007; 92(6): 771 - 777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K Strobel, N. Schaefer, C Renner, P Veit-Haibach, D Husarik, A. Koma, and T. Hany Cost-effective therapy remission assessment in lymphoma patients using 2-[fluorine-18]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography: is an end of treatment exam necessary in all patients? Ann. Onc., April 1, 2007; 18(4): 658 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tatsumi, C. Cohade, Y. Nakamoto, E. K. Fishman, and R. L. Wahl Direct Comparison of FDG PET and CT Findings in Patients with Lymphoma: Initial Experience Radiology, December 1, 2005; 237(3): 1038 - 1045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Juweid, G. A. Wiseman, J. M. Vose, J. M. Ritchie, Y. Menda, J. E. Wooldridge, F. M. Mottaghy, E. M. Rohren, N. M. Blumstein, A. Stolpen, et al. Response Assessment of Aggressive Non-Hodgkin's Lymphoma by Integrated International Workshop Criteria and Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography J. Clin. Oncol., July 20, 2005; 23(21): 4652 - 4661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Mengiardi, H. Honegger, J. Hodler, U. G. Exner, M. D. Csherhati, and W. Bruhlmann Primary Lymphoma of Bone: MRI and CT Characteristics During and After Successful Treatment Am. J. Roentgenol., January 1, 2005; 184(1): 185 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. G. Schaefer, T. F. Hany, C. Taverna, B. Seifert, K. D. M. Stumpe, G. K. von Schulthess, and G. W. Goerres Non-Hodgkin Lymphoma and Hodgkin Disease: Coregistered FDG PET and CT at Staging and Restaging--Do We Need Contrast-enhanced CT? Radiology, September 1, 2004; 232(3): 823 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Guay, M. Lepine, J. Verreault, and F. Benard Prognostic Value of PET Using 18F-FDG in Hodgkin's Disease for Posttreatment Evaluation J. Nucl. Med., August 1, 2003; 44(8): 1225 - 1231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Elstrom, L. Guan, G. Baker, K. Nakhoda, J.-A. Vergilio, H. Zhuang, S. Pitsilos, A. Bagg, L. Downs, A. Mehrotra, et al. Utility of FDG-PET scanning in lymphoma by WHO classification Blood, May 15, 2003; 101(10): 3875 - 3876. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Takahashi, T. Inaoka, N. Murakami, H. Hirota, K. Iwata, K. Nagasawa, T. Yamada, M. Mineta, and T. Aburano Characterization of the Normal and Hyperplastic Thymus on Chemical-Shift MR Imaging Am. J. Roentgenol., May 1, 2003; 180(5): 1265 - 1269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Jerusalem, Y. Beguin, M. F. Fassotte, T. Belhocine, R. Hustinx, P. Rigo, and G. Fillet Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease Ann. Onc., January 1, 2003; 14(1): 123 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Hany, H. C. Steinert, G. W. Goerres, A. Buck, and G. K. von Schulthess PET Diagnostic Accuracy: Improvement with In-Line PET-CT System: Initial Results Radiology, November 1, 2002; 225(2): 575 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Nabi and J. M. Zubeldia Clinical Applications of 18F-FDG in Oncology J. Nucl. Med. Technol., March 1, 2002; 30(1): 3 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps A Tabulated Summary of the FDG PET Literature J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93. [Full Text] [PDF]
|
|
|
|
|
|
M. Tatsumi, H. Kitayama, H. Sugahara, N. Tokita, H. Nakamura, Y. Kanakura, and T. Nishimura Whole-Body Hybrid PET with 18F-FDG in the Staging of Non-Hodgkin's Lymphoma J. Nucl. Med., April 1, 2001; 42(4): 601 - 608. [Abstract] [Full Text]
|
|
|
|
|
|
P. J. Lugtenburg, B. Löwenberg, R. Valkema, H.-Y. Oei, S. W. Lamberts, M. J. Eijkemans, W. L. van Putten, and E. P. Krenning Somatostatin Receptor Scintigraphy in the Initial Staging of Low-Grade Non-Hodgkin's Lymphomas J. Nucl. Med., February 1, 2001; 42(2): 222 - 229. [Abstract] [Full Text]
|
|
|
|
|
|
E. Sutinen, S. Jyrkkio, M. Varpula, P. Lindholm, T. Gronroos, P. Lehikoinen, M. Teras, and H. Minn Nodal Staging of Lymphoma with Whole-Body PET: Comparison of [11C]Methionine and FDG J. Nucl. Med., December 1, 2000; 41(12): 1980 - 1988. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Anzai, S. Minoshima, G. T. Wolf, and R. L. Wahl Head and Neck Cancer: Detection of Recurrence with Three-dimensional Principal Components Analysis at Dynamic FDG PET Radiology, July 1, 1999; 212(1): 285 - 290. [Abstract] [Full Text]
|
|
|
|
 |
|
 V. J Lowe and K. S Naunheim Current role of positron emission tomography in thoracic oncology Thorax, August 1, 1998; 53(8): 703 - 712. [Full Text]
|
|
|
|
|
|
R. Carr, S. F. Barrington, B. Madan, M. J. O'Doherty, C. A.B. Saunders, J. van der Walt, and A. R. Timothy Detection of Lymphoma in Bone Marrow by Whole-Body Positron Emission Tomography Blood, May 1, 1998; 91(9): 3340 - 3346. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |
